Medicines as a service : a new commercial model for big pharma in the postblockbuster world / / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu.
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
Saved in:
Superior document: | RAND Health occasional paper |
---|---|
: | |
TeilnehmendeR: | |
Year of Publication: | 2012 |
Edition: | 1st ed. |
Language: | English |
Series: | Occasional paper (Rand Corporation)
|
Physical Description: | 1 online resource (12 p.) |
Notes: | Description based upon print version of record. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02148nam a2200541 a 4500 | ||
---|---|---|---|
001 | 993628539204498 | ||
005 | 20240516210422.0 | ||
006 | m o d | | ||
007 | cr -n--------- | ||
008 | 120810s2012 cau ob 000 0 eng d | ||
020 | |a 0-8330-7646-9 | ||
035 | |a (CKB)2670000000232840 | ||
035 | |a (EBL)981579 | ||
035 | |a (OCoLC)804665552 | ||
035 | |a (SSID)ssj0000870484 | ||
035 | |a (PQKBManifestationID)11463549 | ||
035 | |a (PQKBTitleCode)TC0000870484 | ||
035 | |a (PQKBWorkID)10818478 | ||
035 | |a (PQKB)10643748 | ||
035 | |a (MiAaPQ)EBC981579 | ||
035 | |a (Au-PeEL)EBL981579 | ||
035 | |a (CaPaEBR)ebr10583965 | ||
035 | |a (OCoLC)893183697 | ||
035 | |a (EXLCZ)992670000000232840 | ||
040 | |a MiAaPQ |c MiAaPQ |d MiAaPQ | ||
041 | |a eng | ||
050 | 4 | |a HD9665.5 |b .M38 2012 | |
082 | 0 | 0 | |a 362.29/90941 |
100 | 1 | |a Mattke, Soeren. | |
245 | 1 | 0 | |a Medicines as a service |h [electronic resource] : |b a new commercial model for big pharma in the postblockbuster world / |c Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
250 | |a 1st ed. | ||
260 | |a Santa Monica, Calif. : |b RAND, |c c2012. | ||
300 | |a 1 online resource (12 p.) | ||
336 | |a text |b txt | ||
337 | |a computer |b c | ||
338 | |a online resource |b cr | ||
490 | 1 | |a RAND Health occasional paper | |
500 | |a Description based upon print version of record. | ||
505 | 0 | |a Medicines as a Service | |
520 | |a The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. | ||
546 | |a English | ||
504 | |a Includes bibliographical references. | ||
650 | 0 | |a Pharmaceutical services. | |
650 | 0 | |a Pharmaceutical industry. | |
700 | 1 | |a Klautzer, Lisa. | |
700 | 1 | |a Mengistu, Tewodaj. | |
710 | 2 | |a RAND Health. | |
830 | 0 | |a Occasional paper (Rand Corporation) | |
906 | |a BOOK | ||
ADM | |b 2024-05-17 03:21:48 Europe/Vienna |f system |c marc21 |a 2012-08-26 09:06:03 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5350500610004498&Force_direct=true |Z 5350500610004498 |b Available |8 5350500610004498 |